Drug–drug interactions in patients undergoing chemoradiotherapy and the impact of an expert team intervention
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy
Link
http://link.springer.com/content/pdf/10.1007/s11096-019-00949-6.pdf
Reference39 articles.
1. Magro L, Moretti U, Leone R. Epidemiology and characteristics of adverse drug reactions caused by drug–drug interactions. Expert Opin Drug Saf. 2012;11:83–94.
2. Greenblatt DJ. Mechanisms and consequences of drug–drug interactions. Clin Pharmacol Drug Dev. 2017;6:118–24.
3. Percha B, Altman RB. Informatics confronts drug–drug interactions. Trends Pharmacol Sci. 2013;34:178–84.
4. Strandell J, Bate A, Lindquist M, Edwards IR, Swedish, Finnish IXDID (SFINX G). Drug–drug interactions—a preventable patient safety issue? Br J Clin Pharmacol. 2008;65:144–6.
5. Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug–drug interactions: population database analysis 1995–2010. BMC Med. 2015;13:74.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potential drug–drug interactions analysis in Polish pediatric pneumonology units, including cystic fibrosis patients;The Journal of Clinical Pharmacology;2024-06-03
2. Prevalence, Attributes, and Risk Factors of QT-Interval-Prolonging Drugs and Potential Drug-Drug Interactions in Cancer Patients: A Prospective Study in a Tertiary Care Hospital;Cureus;2024-05-17
3. Detection of potential drug-drug interactions among ovarian cancer patients in a tertiary care teaching hospital in South India- A retrospective approach;Clinical Epidemiology and Global Health;2023-07
4. Potential Drug-Drug Interactions Between Anti-Cancer Drugs and Other Medications in Lung Cancer Patients: A Retrospective Study;Current Drug Safety;2023-05
5. Prevalence and associated factors of drug-drug interactions in elderly outpatients in a tertiary care hospital: a cross-sectional study based on three databases;Annals of Translational Medicine;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3